Palvella Therapeutics (NASDAQ:PVLA) Earns “Buy” Rating from HC Wainwright
Palvella Therapeutics (NASDAQ:PVLA – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a note issued to investors on Tuesday,Benzinga reports. They presently have a $38.00 price target on the stock. HC Wainwright’s price objective indicates a potential upside of 125.12% from the stock’s current price. PVLA […]
Palvella Therapeutics (NASDAQ:PVLA – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a note issued to investors on Tuesday,Benzinga reports. They presently have a $38.00 price target on the stock. HC Wainwright’s price objective indicates a potential upside of 125.12% from the stock’s current price. PVLA […]
